Posted in | News | Photonics

HORIBA's Multifrequency Fluorometer Revolutionizes Molecular Dynamics

The introduction of the patented technique of MultiFrequency Fluorometry gives you access to a previously uncharted region of fluorescence dynamics. HORIBA Scientific, the only manufacturer of both pulsed and phase lifetime instrumentation, now offers the MF2, which can fully characterize samples on the millisecond scale. Instead of performing the now-obsolete technique of stepping through a sequence of frequencies to isolate the lifetime behavior of a substance, the MF2 applies all frequencies simultaneously so you instantaneously obtain the information you need to extract multiple and distributed lifetimes. Processes that were, till now, inaccessible to other lifetime techniques, such as stopped flow or fast reaction experiments, now eagerly surrender their secrets to the MF2. Choose to excite with LED’s or laser diodes from the uv to nir for maximum sensitivity, or switch quickly to pockel-cell modulation of a xenon lamp for the broadest, continuous coverage. MF2 has all the accessories and data routines you would expect from an instrument of this ultra-sophistication, as well as all of the modular flexibility of the Fluorolog Spectrofluorometer.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    HORIBA. (2018, January 10). HORIBA's Multifrequency Fluorometer Revolutionizes Molecular Dynamics. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=8052.

  • MLA

    HORIBA. "HORIBA's Multifrequency Fluorometer Revolutionizes Molecular Dynamics". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=8052>.

  • Chicago

    HORIBA. "HORIBA's Multifrequency Fluorometer Revolutionizes Molecular Dynamics". AZoM. https://www.azom.com/news.aspx?newsID=8052. (accessed November 21, 2024).

  • Harvard

    HORIBA. 2018. HORIBA's Multifrequency Fluorometer Revolutionizes Molecular Dynamics. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=8052.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.